ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,016Medicare Part D Prescriptions Filled, Including Refills

Rank: 34 out of 2588

$1.31M Total Retail Price of All Prescriptions

Rank: 42 out of 2588

496 Patients Receiving at Least One Drug in Part D
57%Patients 65 Years and Older
94% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

23% of this provider’s 496 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 14,185 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

46 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
SIMVASTATIN 961 647 1 1
FUROSEMIDE 877 572 2 5
POTASSIUM CHLORIDE 790 458 3 15
HYDROCHLOROTHIAZIDE 673 351 4 13
LISINOPRIL 649 441 5 3
HYDROCODONE-ACETAMINOPHEN 578 263 S3 6 7
IBUPROFEN 508 229 7 62
METOPROLOL TARTRATE 495 359 8 9
ALENDRONATE SODIUM 461 370 9 21
METFORMIN HCL 454 297 10 8
AMLODIPINE BESYLATE 420 328 11 4
GABAPENTIN 398 232 12 18
PROAIR HFA 383 211 13 50
FELODIPINE ER 347 178 14 108
METOPROLOL SUCCINATE 337 156 15 12
CLOPIDOGREL 323 239 16 30
PLAVIX 319 241 17 43
TRAMADOL HCL 311 163 18 19
OMEPRAZOLE 280 206 19 6
TAMSULOSIN HCL 280 177 19 23
GLIPIZIDE 266 194 21 44
CARVEDILOL 247 155 22 20
NEXIUM 246 140 23 41
NIFEDIPINE ER 235 150 24 59
ADVAIR DISKUS 231 124 25 48
LEVOTHYROXINE SODIUM 220 123 26 2
HYDRALAZINE HCL 211 113 27 53
GLIPIZIDE XL 209 139 28 140
DONEPEZIL HCL 208 173 29 22
SURE COMFORT 208 111 29 227
ENALAPRIL MALEATE 206 103 31 31
FLUTICASONE PROPIONATE 196 125 32 40
VENTOLIN HFA 187 80 33 101
RAMIPRIL 182 157 34 111
CLONIDINE HCL 180 75 35 54
PANTOPRAZOLE SODIUM 171 120 36 28
WARFARIN SODIUM 167 120 37 10
SERTRALINE HCL 161 72 38 26
PROMETHAZINE HCL 156 88 R 39 180
HYDROCORTISONE 154 62 40 221
RISPERIDONE 154 111 40 57
COMBIVENT 154 95 40 145
NAPROXEN 152 125 43 95
ATORVASTATIN CALCIUM 151 73 44 11
DIOVAN 138 101 45 29
FAMOTIDINE 137 90 46 36
FLUNISOLIDE 136 122 47 262
ZOLPIDEM TARTRATE 136 91 47 24
LANSOPRAZOLE 127 64 49 157
ACTOS 126 98 50 105
ALLOPURINOL 126 64 50 33
LOVASTATIN 123 66 52 34
NITROGLYCERIN PATCH 123 95 52 149
LACTULOSE 117 97 54 135
LIPITOR 115 62 55 114
NAMENDA 114 114 56 32
NIZATIDINE 113 72 57 213
LANTUS 111 42 58 47
SPIRIVA 111 94 58 56
TRAVATAN Z 109 92 60 232
RANITIDINE HCL 108 75 61 37
CRESTOR 107 70 62 25
CALCITRIOL 101 67 63 210
VESICARE 100 57 64 172
CYCLOBENZAPRINE HCL 98 34 R 65 87
OXYBUTYNIN CHLORIDE ER 96 74 66 85
LIDODERM 95 91 67 86
TRIAMCINOLONE ACETONIDE 93 57 68 106
TRAZODONE HCL 78 29 69 61
AGGRENOX 76 48 70 214
EVISTA 75 52 71 178
LOSARTAN POTASSIUM 75 65 71 17
NITROSTAT 74 40 73 181
SINGULAIR 73 48 74 94
PHENYTOIN SODIUM EXTENDED 72 55 75 109
KLOR-CON M20 70 56 76 52
ACETAMINOPHEN-CODEINE 70 34 S3 76 80
DIGOXIN 69 69 78 38
ROPINIROLE HCL 68 39 79 113
DIOVAN HCT 67 45 80 72
AMITRIPTYLINE HCL 67 38 R 80 91
MEGESTROL ACETATE 65 59 R 82 169
SYMBICORT 64 39 83 129
NOVOLIN 70-30 61 40 84 244
ESCITALOPRAM OXALATE 60 35 85 68
METOLAZONE 58 40 86 152
LYRICA 57 21 87 100
SPIRONOLACTONE 57 28 87 58
HEPARIN SODIUM 55 49 89 79
GEMFIBROZIL 55 22 89 123
CITALOPRAM HBR 54 44 91 27
BUPROPION HCL SR 53 36 92 246
ABILIFY 52 0 93 134
FLUOXETINE HCL 52 0 93 92
GLYBURIDE 51 27 R 95 65
FLOVENT HFA 51 33 95 191
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 28, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.